Fisher & Paykel Healthcare lifted its full-year earnings guidance as it benefits from increased demand on the back of the covid-19 virus outbreak.
"We've seen better-than-expected sales in our homecare product group combined with continued strong growth in our hospital product group. This includes an increase in demand from China related to the covid-19 coronavirus outbreak," said chief executive Lewis Gradon.
The Auckland-based maker of hospital equipment and personal sleep apnea products now expects full-year operating revenue to be approximately $1.2 billion for the year ending March 31. It raised its net profit forecast to between $260 million and $270m
Its November forecast was for operating revenue of $1.19b and net profit of $255m to $265m.
In both cases, the New Zealand dollar was assumed to be 64 US cents, it said. The kiwi recently traded at 63.32 US cents.